Links to Publications:


Wexler, D.E., Potochnik, K.A. (eds.). Modern Concepts in Alzheimer’s Disease. 1998, Brookfield, WI, USA



Cleary, P.P., S. Porter, and D.E. Wexler. 1985. A streptococcal inactivator of chemotaxis: a new virulence factor specific to group A streptococci. In: Recent Advances in Streptococci and Streptococcal Diseases, Eds. Y. Kinura, S. Kotami, and Y. Shinkawa, pp.179-180.


Lefebvre, P.A., S-E. Barsel, M. Stuckey, L. Swartz, and D. Wexler. 1985. Genetic analysis of flagellar gene expression in Chlamydomonas. In: Microtubules and Microtubule Inhibitors, Eds. M. De Brabander and J. De May.


Refereed Publications:

Cleary P.P., U. Prahbu, J.B. Dale, D.E. Wexler, and J. Handley. 1992. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect. Immun. 60:5219-5222.


Segatto, O., F. Lonardo, K. Helin, D. Wexler, F. Fazioli, S.G. Rhee, and P.P. DiFiore. 1992. ErbB-2 autophosphorylation is required for mitogenic action and high-affinity substrate coupling. Oncogene 7:1339-1346.


Segatto, O., F. Lonardo, D. Wexler, F. Fazioli, J.H. Pierce, D.P. Bottaro, M.F. White, and P.P. DiFiore. 1991. The juxtamembrane regions of the epidermal growth factor receptor and gp185erbB-2 determine the specificity of signal transduction. Mol. Cell. Biol. 11:3191-3202.


Lefebvre, P.A., S-E. Barsel, and D. Wexler. 1989. Isolation and characterization of Chlamydomonas reinhardtii mutants with defects in the induction of flagellar protein synthesis after deflagellation. J. Protozoology 35:559-564.


Barsel, S-E., D.E. Wexler, and P.A. Lefebvre. 1988. Genetic analysis of long-flagella mutants of Chlamydomonas reinhardtii. Genetics 118:637-648.


Wexler, D.E., D.E. Chenoweth, and P.P. Cleary. 1985. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl. Acad. Sci. USA 82:8144-8148.


Wexler, D.E., and P.P. Cleary. 1985. Purification and characteristics of the streptococcal chemotactic factor inactivator. Infect. Immun. 50:757-764.


Wexler, D.E., R.D. Nelson, and P.P. Cleary. 1983. Human neutrophil chemotactic response to group A streptococci; bacteria-mediated interference with complement-derived chemotactic factors. Infect. Immun. 39:239-247.


Delihas, N., E. Bagley, C. Prokop, and D. Wexler. 1979. The binding of streptomycin to ribonucleotides. J. Antibiotics 32:1174-1180.


Cleary, Paul P. and Daniel E. Wexler. 1988. Inhibitor of C5a-mediated chemotaxis. United States Patent 4,772,584.

Published Poetry:

Daniel Wexler.  The Planting. 2005-2010:


Webzine Publications:

Wexler, D.E. 1997. Will Microbes Conquer the Human Race? The Science Tribune,

2019 Entrez PubMed: C5a Peptidase-Related Research Articles